The long road to returning first-ever samples from Mars – CNN

It's the site of an ancient lake bed and river delta that existed between 3 and 4 billion years ago -- when Mars was warmer, wetter and habitable for potential life.

The complicated route to the Mars Sample Return mission involves NASA collaborating with the European Space Agency and international partners. And given the difficulty of this multi-pronged return journey of the samples, they won't land on Earth until 2031, at the earliest.

"Perseverance is the first step in the first ever round trip mission to another planet in our solar system," said Lori Glaze, director of NASA's Planetary Science Division at NASA Headquarters in Washington, during a press conference. "Scientists have wanted a sample of Mars to study for generations. Now, we're at a point to begin to attempt this amazing feat."

Roving back in time

Unlike Earth, Mars doesn't have a "young surface" because it's not active in the same way our planet is with moving plate tectonics, volcanic eruptions and other processes that tend to erase the history sitting on Earth's surface. So when Perseverance roves across Jezero Crater, it will be able to observe and sample the well-preserved past of Mars.

Scientists estimate that water filled the impact crater to form a lake about 3.8 billion years ago -- right when life was starting on Earth, according to Briony Horgan, member of the Perseverance science team and associate professor of planetary science at Purdue University. The lake was half the size of Lake Ontario (which is 53 miles wide and has an average depth of 283 feet) and almost as deep.

The river delta, which resembles the Mississippi River delta, once fed into the lake and signifies that the lake persisted for a long time. On the other side of the lake bed, a river channel can be seen where water carried away from the crater.

The delta may be the most intriguing area for Perseverance to explore because it preserves the bottom of the lake -- mud, organic materials, signs of ancient life and potentially even fossils of microbes could be preserved in the bottom of the delta, Horgan said.

Based on images provided by the Mars Reconnaissance Orbiter, which was launched in 2005, scientists already know there are interesting minerals around the rim of the crater called carbonates. On Earth, carbonates preserve the fossils of ancient life. These carbonates mark what scientists believe was once an ancient shoreline for the lake. When water precipitated here, it could have helped fossilize life or organic molecules signifying it in the form of carbonates.

First, Perseverance will explore the river delta, followed by the crater rim, and eventually, "drive out of the crater and explore the wonderland of the earliest history of Mars," according to Benjamin Weiss, a professor of planetary sciences at the Massachusetts Institute of Technology and one of the Returned Sample scientists for Perseverance. Weiss is on a team that will make determinations of where and when to collect samples -- and hopes to analyze them once they return to Earth.

The first Martian samples

Perseverance has a sophisticated system to collect samples, cache them and stow them on the Martian surface. And in order to do this, its hardware had to be meticulously cleaned on Earth to prevent any potential contamination of the Martian site with microbes from Earth -- or provide a false positive for potential life on Mars.

"It's the cleanest system we've ever launched," said Matt Wallace, Perseverance deputy project manager at NASA's Jet Propulsion Laboratory in Pasadena, California. "The science community is looking for trace signatures from billions of years ago. We don't want to confuse that search."

While Perseverance has the ability to fill 43 sample tubes over the course of its two-year exploration of the 28-mile-wide crater and the surrounding area, there will only be space for 31 of the tubes to return to Earth.

So the science team, which includes hundreds of people, will have to work together on when and where to collect samples. The difference in the amount of samples the rover can collect versus the ones that will return provides the scientists with some wiggle room should they decide to abandon one sample for a better one.

But once filled, the tubes cannot be emptied.

"The key for this mission will be identifying samples so compelling that we can't afford to leave them, so it is imperative that missions have to go get them," Weiss said. "We are selecting these for humanity, so we need to make sure they are the most exciting."

The scientists will be looking for patterns or textures in rocks that act like records of life -- similar to some of the oldest known rocks on Earth in Western Australia from 3.48 billion years ago.

Over time, these form layered rocks called stromatolites.

"The best place to look for life is a place where you think life could have existed," said Ken Farley, project scientist for Perseverance at the California Institute of Technology. "The current surface of Mars is too cold and too dry for any life we know about to exist. Billions of years ago, it was much warmer with water on the surface. Rocks deposited at that time were in habitable environments and they record them."

Lunar samples returned to Earth by the Apollo missions have changed our understanding of the moon over the last 50 years, including how it may have formed.

Weiss has worked on research using the samples collected during the latter years of the Apollo program. Some have remained sealed for 50 years until new technology and instruments were developed to help better understand them.

Weiss wants the same approach to be taken regarding samples from Mars.

"We can't get trapped by selecting samples just based on what current instruments can measure," Weiss said. "We can't conceive what instruments can be like 100 years from now. But if we sample from places that may be habitable, that will keep them interesting for years to come."

Returning the samples to Earth

Collecting samples on the Mars surface is just the first step.

"It's a really complex concept to bring them back," Glaze said. "It will require multiple steps and multiple launches."

In 2026, NASA and ESA will launch the Mars Ascent Vehicle lander and rocket carrying the Sample Fetch Rover. Perseverance will witness and share images of the landing of this spacecraft on Mars when it occurs in 2028 -- a first.

The lander will release the fetch rover on the Martian surface. This small rover, similar to NASA's earlier rovers, will collect the samples and carry them back to the lander. It's possible that Perseverance could also deliver the samples itself.

The fetch rover will need to work quickly over the course of eight months during the Martian spring and summer before winter's dust obscures the atmosphere. This lightweight "Martian dune buggy" will be designed for speed to accomplish its goals, said David Parker, director of human and robotic exploration at the European Space Agency.

The samples will be transferred to the ascent vehicle and it will blast off from the surface of Mars -- another first that will be witnessed by Perseverance.

The ascent vehicle will rendezvous with an ESA spacecraft orbiting Mars and shoot out a football-size container holding the samples. The ESA orbiter will capture the container during this pass between spacecrafts and head back toward Earth.

Close to Earth, a NASA payload on the orbiter will put the container of samples in an entry vehicle that can be deployed from the orbiter and land the samples on Earth in 2031.

The samples will land in Utah and be transported to a type of facility usually associated with the handling of biohazards.

Then, scientists from around the world will be able to study and analyze the chemical and physical properties of these rock and soil samples for Mars, searching for signs of past life.

"This is the manifestation of a lot of dreams and aspirations by scientists," said Thomas Zurbuchen, associate administrator of NASA's Science Mission Directorate. "Samples from Mars have the potential to profoundly change our understanding of life."

Read the original:

The long road to returning first-ever samples from Mars - CNN

Meet the 3 Spacecraft Heading to Mars This Summer – The New York Times

This summer, three missions are setting out on a journey of millions of miles. Bound for Mars, the trio carry an array of state-of-the-art instruments to explore the red planet.

Hope was the first spacecraft to launch to Mars this summer, and the first Mars mission for the United Arab Emirates.

The orbiter will observe Mars from space, forming a detailed picture of the planets atmosphere and its weather with a suite of imaging devices. A camera will capture high-resolution images of the planet. An infrared spectrometer will study dust, ice clouds, water vapor and temperature in the lower atmosphere. And an ultraviolet spectrometer will investigate carbon monoxide, hydrogen and oxygen in the upper atmosphere.

ANTENNA

A six-foot antenna will communicate with Earth

THERMAL BLANKET

A protective layer of insulation around the orbiter gives it a gold appearance

SOLAR PANELS

Will unfurl after launch and charge the onboard battery

Hope is about as tall as a person and weighs almost 3,000 pounds

CAMERA

Will capture high-resolution images of Mars

Infrared Spectrometer

Will study dust, ice clouds, water vapor and temperature in the lower atmosphere

ULTRAVIOLET SPECTROMETER

Will investigate carbon monoxide, hydrogen and oxygen in the upper atmosphere

ANTENNA

A six-foot antenna will communicate with Earth

THERMAL BLANKET

To protect from extreme temperatures

Hope is about as tall as a person and weighs almost 3,000 pounds

SOLAR PANELS

Will charge the onboard battery

Hope is about as tall as a person

Source: Mohammed Bin Rashid Space Center

China is sending an orbiter, lander and rover to Mars the only mission this year to attempt a three-pronged exploration. After the spacecraft reaches Mars, the landing pod will detach from the orbiter and descend to the planets surface. The orbiter will remain in space and observe the planet using seven instruments.

A parachute attached to the landers protective shell will slow the descent. Next, a set of struts will deploy midair. A thruster attached to the bottom of the lander will also help guide the vehicle to a softer landing.

Once on the surface, a ramp will slide out so the rover can drive away. The rover has two sets of solar panel wings that will unfurl after landing.

Lander

A parachute attached to a protective SHELL will slow the landers descent. Next, a set of STRUTS will deploy midair. Once on the surface, a RAMP will slide out so the rover can drive off.

Orbiter

After the orbiter reaches Mars, the landing probe will detach and descend to the planets surface.

Rover

Four solar panel wings will unfurl after landing.

Orbiter

After the orbiter reaches Mars, the landing probe will detach and descend to the planets surface.

Lander

A parachute attached to a protective SHELL will slow the descent. Next, a set of STRUTS will deploy midair. After landing, a RAMP will slide out so the rover can drive off.

Rover

With four solar panels

Orbiter

After the orbiter reaches Mars, the landing probe will detach and descend to the planets surface.

Lander

A parachute attached to the SHELL will slow the descent. Next, four STRUTS will deploy midair. After landing, a RAMP will slide out so the rover can drive off.

Rover

Four solar panel wings will unfurl after landing.

Source: China National Space Administration and China Central Television

The NASA mission includes Perseverance, a 2,200-pound rover, and Ingenuity, an experimental Mars helicopter. The Ingenuity helicopter weighs about four pounds, and will be the first to attempt powered flight on another planet.

The Perseverance rovers design is based on Curiosity, a successful NASA mission that landed on Mars in 2012. The plutonium power supply is designed to last more than a decade. The rover carries 19 cameras and a drill to extract core samples from rocks.

Perseverance also uses a suspension system to drive over obstacles. The rover can turn a full 360 degrees in place, using six individually motorized aluminum wheels.

Ingenuity Helicopter

The four-pound aircraft will communicate wirelessly with the Perseverance rover.

Blades

Four carbon-fiber blades will spin at about 2,400 r.p.m.

Power

The plutonium-based power supply will charge the rovers batteries.

MAST

Instruments will take videos, panoramas and photographs. A laser will study the chemistry of Martian rocks.

PiXl

Will identify chemical elements to seek signs of past life on Mars.

Antenna

Will transmit data directly to Earth.

Robotic arm

A turret with many instruments is attached to a 7-foot robotic arm. A drill will extract samples from Martian rocks. The Sherloc device will identify molecules and minerals to detect potential biosignatures, with help from the Watson camera.

Perseverance Rover

The 2,200 pound rover will explore Jezero Crater. It has aluminum wheels and a suspension system to drive over obstacles.

Ingenuity Helicopter

The aircraft will communicate wirelessly with the rover.

Power

The plutonium-based power supply will charge the rovers batteries.

MAST

Instruments will take videos, panoramas and photographs. A laser will study the chemistry of Martian rocks.

PiXl

Will identify chemical elements to seek signs of past life on Mars.

Robotic arm

A turret with many instruments is attached to a 7-foot robotic arm. A drill will extract samples from Martian rocks. The Sherloc device will identify molecules and minerals to detect potential biosignatures, with help from the Watson camera.

Perseverance Rover

The 2,200 pound rover will explore Jezero Crater. It has aluminum wheels and a suspension system to drive over obstacles.

Robotic arm

A turret with many instruments is attached to a 7-foot robotic arm. A drill will extract samples from Martian rocks. The Sherloc device will identify molecules and minerals to detect potential biosignatures, with help from the Watson camera. PiXl will identify chemical elements to seek signs of past life on Mars.

Source: NASA

Once all of the missions have launched, their expected arrival at Mars is in February. The trio will join dozens of other spacecraft, past and present, already hurtling through our solar system.

See the article here:

Meet the 3 Spacecraft Heading to Mars This Summer - The New York Times

Coming of Age on Mars – The New York Times

At Georgetown, Dr. Johnson runs her own lab, which studies old rocks for signs of ancient exotic life of the sort that might be found on Mars or some other extreme world.

The labs website is festooned with pictures of her and colleagues combing the rocks and sands in Antarctica, Australia and the Atacama Desert in Chile, for signs of ancient life. She is also a visiting scientist at NASAs Goddard Space Flight Center, where she is part of a team working with Curiosity, NASAs older rover now climbing a mountain in a crater on Mars. And she hopes one day to be analyzing rocks returned from Mars in her lab.

Reached over Zoom in Kentucky, where she was visiting family, Dr. Johnson radiated an easy, unflappable manner. She responded to questions with a wide smile, as if the light had just broken on her face, and a drawn-out Yeah as she mulled her answers.

In Sirens of Mars, Dr. Johnson chronicles the personalities, the surprises, the dashed expectations and the claims made and abandoned of the discovery of life on Mars. Its also a personal chronicle; the due date for her first pregnancy, in August 2012, coincided with the landing of the Curiosity rover on Mars, temporarily derailing her chances of participating in what was the biggest Mars mission yet. She watched her colleagues at the Jet Propulsion Laboratory on television, saddened that Mars might be slipping away.

Opportunities only come around so often, she writes. The planets aligned and then swung apart.

She had not set out to make herself a character in the book, she said. The project began with the habit of writing down poignant and evocative things that would never make it into scientific journals, and grew from there.

I guess at some point it just felt like Mars deserved a different kind of treatment, she said. You know, something that will capture a lot of the mystery and the wonder of the whole endeavor, the whole search for life..

See the original post here:

Coming of Age on Mars - The New York Times

With Perseverance and a little MOXIE, MIT is going to Mars – MIT News

On July 30, a two-week window of opportunity opens for Perseverance the newest Mars rover, forged in the spirit of human curiosity to begin its journey toward the Red Planet with a launch from the Cape Canaveral Space Launch Center on the eastern Florida coast. With MITs help, this latest NASA mission will build upon the legacy of its roving laboratory predecessors and dig deeper than ever before into questions about life on Mars.

In its current state, Mars is inhospitable; the surface is dusty, and the only available water is frozen near the poles, deep underground, or so tightly bound to the soil that it would have to be cooked in an oven to extract it. The air is unbreathable, and the thin atmosphere allows worrisome levels of radiation while maintaining an average temperature of -81 degrees Fahrenheit. At one time in the past, however, it may have looked a lot more like Earth, and may have been more sustainable for life.

The goals of Perseverance a signature component of the larger Mars 2020 mission are to explore questions of this former habitability, to characterize the environment, and to help pave the way for future human exploration. One of seven experiments traveling on the rover will specifically address future human missions to Mars: MOXIE, short for the Mars OXygen In situ resource utilization Experiment, will help us prepare for those first missions by demonstrating that we can make our own oxygen on Mars to use for rocket propellant and for the crew to breathe when astronaut explorers arrive there. MOXIE was proposed and developed through a collaboration between researchers at MITs Haystack Observatory and the MIT Department of Aeronautics and Astronautics (AeroAstro), along with engineers at NASA Jet Propulsion Laboratory (JPL).

MIT is well-represented in other aspects of the mission as well. Perseverance will carry a sophisticated system for selecting, coring, caching, and preserving rock and soil samples to someday bring back to Earth. Professor of geobiology and member of the mission's Project Science Group Tanja Bosak and professor of planetary sciences Ben Weiss, both from the MIT Department of Earth, Atmospheric, and Planetary Sciences (EAPS), are participating scientists on a 10-person Return Sample Selection team. With expertise in biogeochemical and sedimentological processes in microbial systems, and paleomagetism and planetary geophysics, they're tasked with helping to identify promising samples on the Martian surface to core, collect, and analyze for signs of previous life and evolution of the planet's habitability. And Ariel Ekblaw, a graduate student in media arts and sciences and the founder and lead of the MIT Media Lab Space Exploration Initiative, contributed to a rover experiment during a summer at JPL that will search for evidence of past microbes.

The little mechanical tree

In the 2015 filmThe Martian, when astronaut Mark Watney (played by Matt Damon) was left stranded on Mars, he managed to survive long enough to coordinate a rendezvous rescue mission with his crew by living off the land of the Red Planet. This is the basic principle behind in situ resource utilization, or ISRU, and MOXIE represents an important first step in realizing ISRU for future Mars explorers.

Not only do you need oxygen for people to breathe, but you need it for the rocket to breathe too. If you are burning fuel, you need oxygen to consume it, says Michael Hecht, MOXIE principal investigator and director of research at MIT Haystack Observatory in Westford, Massachusetts. There is a reason why oxygen tanks are the heaviest items on a spaceflight manifest.

Launches consume a lot of fuel: Propelling a spacecraft to exit the Earths gravitational pull requires a great deal of energy, and returning back to Earth requires doing it all over again. What's more, the heavy tanks required to transport the oxygen needed for a given mission take up precious real estate in a carefully calibrated spacecraft. This is where the ISRU approach comes in.

Instead of taking it with us, why not just make it when we get there as we need it? Hecht says. Oxygen exists on Mars, just not in a form we can use it. So that is the problem we were trying to solve with MOXIE.

MOXIE will collect carbon dioxide (CO2) from the Martian atmosphere and electrochemically split the it into oxygen and carbon monoxide molecules. Animation: NASA/JPL

One potential source of oxygen is ice that exists under the Martian surface. But mining this ice would require complex machinery, and the physical act of digging and drilling would put significant wear and tear on equipment, which is a problem when a repair person is a planet away. Thankfully, there was another potential resource the team can tap to generate oxygen: the atmosphere.

With the mining approach, you have to mine the ice, refine and process it to release the oxygen, and bring it back, which is just not something we can do robotically, especially within our space constraints, says Hecht. I wanted to find a much simpler approach. The Martian atmosphere is about 96 percent carbon dioxide, so we built a little mechanical tree, because that is much easier than building a miniature, self-contained mining company.

MOXIEs objective: collect the carbon dioxide abundant in Martian air, convert it to oxygen, and measure the oxygens purity. After pulling in Martian air, the system filters out dust, compresses it, and then feeds it into the Solid OXide Electrolyzer (SOXE), the key element that takes pressurized carbon dioxide and uses a combination of electricity and chemistry to split the molecule into oxygen and carbon monoxide. The purity of the oxygen is analyzed, and then the oxygen is released back into the Martian atmosphere.

Currently, the plan is to perform at least 10 oxygen-producing runs throughout the mission under as many different seasonal and environmental conditions as possible. Due to the intense amount of energy required to run the MOXIE experiment, the team will coordinate with the other researchers, who will have to power down for the duration of MOXIEs several-hour run time, and then wait for most of a Martian day (called asol) for Perseverances batteries to recharge. The data will be sent back to a lab on MITs campus, where MOXIEs performance will be analyzed.

Assembling the team

In 2013, NASA put out a call for proposals for oxygen-generating experiments for the 2020 rover within specific parameters. Despite working on the Phoenix Mars Lander mission during his 30-year tenure at JPL, when Hecht moved to his current position at MIT Haystack Observatory in 2012, he didnt expect to be a Mars guy anymore he thought he was done with Mars for good. But his former JPL colleagues disagreed and asked him to lead the experiment as principal investigator. According to Hecht, even after he signed on, he believed the project proposal was a long shot, but inJuly 2014, he and his colleagues got word that they landed the project.

Researchers at other NASA labs had a huge head start and a lot of technology heritage. MOXIEs selection was a huge surprise to me, says Hecht. Since this mission has a human-centered focus, I knew we had to establish real credibility with the human exploration community, that we werent just looking for an excuse to do some interesting science. So, how do we convince them that we are for real and we want to help with human exploration? It took me about five minutes to think of Jeff Hoffman.

Hoffman, a professor of the practice in MIT AeroAstro, certainly knows a thing or two about human space exploration. He logged four spacewalks on his five space flights during his career as a NASA astronaut including the initial rescue/recovery mission to repair the Hubble Space Telescope in 1993.

In addition to Hoffmans extensive experience with human spaceflight, he shared another connection with Hecht: Hecht was Hoffmans first graduate student advisee as a new MIT researcher before he was called up to enter the astronaut program in 1978 and pursue a career with NASA. He returned to the MIT faculty in 2001, and in addition to being deputy principal investigator on MOXIE, he directs the Human Systems Lab at MIT and teaches courses about human spaceflight systems.

Its a great experience to collaborate with a former graduate student as colleagues, especially on a project like MOXIE because it shows how important graduate students are to the research process in a story that comes full-circle, says Hoffman. Not only do graduate students carry out the day-to-day work on a project, but we are also developing the next generation of people who will carry on the exploration of not just Mars, but the entire solar system.

AeroAstro PhD students Eric Hinterman SM18 and Maya Nasr 18 have been on the MOXIE team since 2016, when Hinterman was working on his masters degree and Nasr was performing a MOXIE-related research project as a junior in aeronautics and astronautics.

For her masters thesis, Nasr focused on calibrating the sensors in the MOXIE unit by performing experiments under different pressures and temperatures and conditions that mimic the environment on Mars. The goal of her masters work was to understand how the sensors may behave differently in an environment like that of Mars, and to calibrate them accordingly so they would send back accurate data while on the mission. Her PhD work will focus on processing and analyzing both the MOXIE experimental laboratory data and telemetry data that will be sent back from Mars, which will help determine how well the unit functions at its task of extracting oxygen.

For me personally, it means a lot to work on this project and its amazing that the launch is already happening. I grew up in Lebanon and remember watching the Curiosity Rover landing, and at the time the NASA JPL director was Dr. Charles Elachi, who is originally Lebanese, says Nasr. Seeing him in mission control made me realize that it was possible to be part of a Mars mission, and its one of the reasons why I applied to MIT.

The newest member of the MOXIE team is AeroAstro masters student Justine Schultz, who joined in the late spring of 2020. Schultz, who also works full time at General Electric, will focus her graduate work on constructing a detailed thermal model of MOXIE.

Whats in a name?

Since Mars OXygen In situ resource utilization Experiment is a mouthful, Hecht wanted to get creative with the project name. The initial inspiration comes from Moxie soda, which was invented in Massachusetts in the 1800s as a nerve-calming tonic. When the company mixed it with soda water for added carbonation, it started flying off the shelves and became one of the first mass-produced sodas in the U.S.

In addition to the local connection and the important role of carbon dioxide in Moxie sodas success story, Hecht thought the meaning behind the word that has become part of our cultural lexicon was particularly fitting to the project.Merriam-Websterdefinesmoxieas energy, pep, courage, determination, and know-how. The deeper meaning became even more relevant as the world grappled with a dangerous global pandemic with the finish line in sight.

The situation with the coronavirus certainly caused some delays from where we thought we would be, but thankfully it never endangered the mission. Despite some setbacks, we were able to pivot and adapt to keep the launch on track, said Hecht. But Covid-19 be damned, we are launching this rover.

The launch window is an important factor because it marks the period of time where Earths orbit around the sun is aligned with that of Mars in such a way to allow a rocket to follow a flight trajectory like changing lanes in a highway to rendezvous with its target landing point on Mars Jezero Crater. The window closes on Aug. 15, and wont open again for another 26 months.

While it will be sad not to have that moment of celebration in person together, the critical thing is that we are going to get on the surface Mars and produce oxygen, which we will be doing online from home, says Hoffman. Looking at everything that has happened over the past few months and all the people who have worked hard to get Mars 2020 ready for launch despite the world around us closing down, Im happy we went with the name Perseverance because hanging in there and persevering with the mission has become the name of the game.

Excerpt from:

With Perseverance and a little MOXIE, MIT is going to Mars - MIT News

Aircraft Ailerons MARKET (IMPACT OF COVID-19) TO SEE MASSIVE GROWTH BY 2026| Saab AB, Sealand Aviation, ShinMaywa Industries, TATA, Bombardier and…

It is our aim to provide our readers with report for Aircraft Ailerons Market, which examines the industry during the period 2020 2026. One goal is to present deeper insight into this line of business in this document. The first part of the report focuses on providing the industry definition for the product or service under focus in the Aircraft Ailerons Market report. Next, the document will study the factors responsible for hindering and enhancing growth in the industry. After covering various areas of interest in the industry, the report aims to provide how the Aircraft Ailerons Market will grow during the forecast period.

The major vendors covered:

Saab AB, Sealand Aviation, ShinMaywa Industries, TATA, Bombardier, Asian Composites Manufacturing (ACM), Turkish Aerospace Industries (TAI). and more

The final report will add the analysis of the Impact of Covid-19 on Aircraft Ailerons Market.

Request a sample copy @ https://www.reportsandmarkets.com/sample-request/global-aircraft-ailerons-market-insights-forecast-to-2026?utm_source=thedailychronicle&utm_medium=38

The Aircraft Ailerons Market report between the years 2020 2026 will highlight the current value of the industry. At the same time, there is also an estimate of how much this line of business will be worth at the end of the forecast period. As it is our goal to maintain high levels of accuracy at all times, we will take a look at the CAGR of the Aircraft Ailerons Market. We make sure that all the information available in this report has excellent levels of readability. One way we achieve this target is by Aircraft Ailerons Market segmentation. Going through the report for 2020 2026 will bring our readers up-to-date regarding this industry.

While examining the information from this document, one thing becomes clear, the elements which contribute to increase in demand for the product or service. At the same time, there will be a focus on what drives the popularity of these types of products or services. This report is for those who want to learn about Aircraft Ailerons Market, along with its forecast for 2020 2026. Information regarding market revenue, competitive partners, and key players will also be available.

Segmentation

As discussed earlier, there is segmentation in the Aircraft Ailerons Market report, to improve the accuracy and make it easier to collect data. The categories which are the dividing factors in the industry are distribution channels, application, and product or service type. With this level of segmentation, it becomes easier to analyze and understand the Aircraft Ailerons Market. At the same time, there is emphasis on which type of consumers become the customers in this industry. When it comes to distribution channels, the Aircraft Ailerons Market report looks at the different techniques of circulation of the product or service.

Inquire more about this report @ https://www.reportsandmarkets.com/enquiry/global-aircraft-ailerons-market-insights-forecast-to-2026?utm_source=thedailychronicle&utm_medium=38

Regional Overview

In this part of the Aircraft Ailerons Market report, we will be taking a look at the geographical areas and the role they play in contributing to the growth of this line of business. The areas of interest in this document are as follows Middle East and Africa, South and North America, Europe, and Asia Pacific. From the Aircraft Ailerons Market report, it becomes clear which region is the largest contributor.

Latest Industry News

From this Aircraft Ailerons Market report, the reader will also get to learn about the latest developments in the industry. The reason is that these products or services have the potential to disrupt this line of business. If there is information about company acquisitions or mergers, this information will also be available in this portion of the Aircraft Ailerons Market report.

Order a purches copy @ https://www.reportsandmarkets.com/checkout?currency=one_user-USD&report_id=4020535&utm_source=thedailychronicle&utm_medium=38

If you have any special requirements about this Aircraft Ailerons Market report, please let us know and we can provide custom report.

About Us

ReportsAndMarkets.com allocates the globally available market research and many company reports from reputed market research companies that are a pioneer in their respective domains. We are completely an autonomous group and serve our clients by offering the trustworthy available research stuff, as we know this is an essential aspect of Market Research.

Contact Us

Sanjay Jain

Manager Partner Relations & International Marketing

http://www.reportsandmarkets.com

Ph: +1-352-353-0818 (US)

Read more:

Aircraft Ailerons MARKET (IMPACT OF COVID-19) TO SEE MASSIVE GROWTH BY 2026| Saab AB, Sealand Aviation, ShinMaywa Industries, TATA, Bombardier and...

Value of Birch Water Market Predicted to Surpass US$ by the of 2017 – 2025 – Market Research Correspondent

Evaluation of the Global Birch Water Market

The presented study maps the growth trajectory of the global Birch Water market by thoroughly assessing the various factors that are expected to influence the future prospects of the Birch Water market. According to the report published by PMR, the Birch Water market is poised to attain a value of ~US$ XX Mn/Bn by the end of 2029 with a CAGR growth of ~XX% during the forecast period (2019-2029).

A complete evaluation of the trends, market drivers, opportunities, and challenges faced by market players operating in the Birch Water market is provided in the report. Further, an overview and introduction of the Birch Water market is included to ensure that the readers have a seamless experience while going through the contents of the report.

Request Sample Report @ https://www.persistencemarketresearch.co/samples/21088

Critical insights included in the report:

Competitive Outlook

The competitive outlook assessment provides an in-depth understanding related to the business proceeding of top-tier market players in the global Birch Water market. The product portfolio, sales strategy, marketing & promotional strategy, and sales footprint of each market player is scrutinized thoroughly in the report. Some of the leading players evaluated in the report include:

The report segments the global Birch Water market on the basis of region, product type, and end use.

Key Players:

The key player in the birch water market includes Nature On Tap Ltd, Sibberi Ltd., Sapp, Inc., BelSeva, Sealand Natural Resources Inc., TreeVitalise, Treo Brands LLC among others.

The report covers exhaustive analysis on:

Regional analysis for Birch Water Market includes:

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and regions.

Report Highlights:

Request Report Methodology @ https://www.persistencemarketresearch.co/methodology/21088

Regional Analysis

The market scenario in each region along with a comprehensive assessment of the micro and macro-economic factors that are forecasted to impact the market growth in these regions is included in the report.

End Use Assessment

The market study offers accurate and in-depth analysis of the various end uses of the Birch Water along with a yearly comparison of the market share and revenue growth of each end use.

Important queries addressed in the report:

For any queries get in touch with Industry Expert @ https://www.persistencemarketresearch.co/ask-an-expert/21088

Why Opt for PMR?

Visit link:

Value of Birch Water Market Predicted to Surpass US$ by the of 2017 - 2025 - Market Research Correspondent

Police arrest suspect connected to apparent killing of professional poker player Susie Zhao – ABC News

August 1, 2020, 9:47 PM

2 min read

Police in White Lake Township, Michigan, have arrested a 60-year-old man in connection to the death of a professional poker player.

The body of Susie Zhao was found burned in a parking lot on July 13, police said.

Detectives with the White Lake Township Police Department were notified by the FBI on Friday that they'd located a vehicle belonging to a 60-year-old Pontiac resident wanted in connection to Zhao's death.

The vehicle was stopped in the area of Interstate 275 and Michigan Avenue, and the man, yet to be identified by authorities, was arrested.

Susie Zhao, 33, a professional poker player also known as Susie Q., was found dead on July 23, 2020, in a parking lot in Lake Township, Mich. A 60-year-old man was taken into custody in relation to her murder on July 31.

Susie Zhao, 33, a professional poker player also known as Susie Q., was found dead on July 23, 2020, in a parking lot in Lake Township, Mich. A 60-year-old man was taken into custody in relation to her murder on July 31.

"The complaint will be forwarded to the Oakland County Prosecutors office review," Detective Lt. Christopher Hild said in a statement.

Zhao, 33, was a resident of Waterford Township and recently relocated to California. She was known professional as "Susie Q" and was featured in ESPN World Series Poker events during 2012, 2015 and 2017, according to her online obituary.

A graveside memorial service for Zhao took place on Saturday at White Chapel Memorial Cemetery in Troy, Michigan.

The investigation continues and anyone with information is encouraged to contact the FBI at 1-800-CALLFBI or submit tips at tips.fbi.gov.

Read the rest here:

Police arrest suspect connected to apparent killing of professional poker player Susie Zhao - ABC News

Why Daniel Negreanu Thinks Phil Ivey Is the Best Poker Player in the World – NBC Chicago

Six-time World Series of Poker bracelet winner Daniel Negreanu has seen everything and everyone at live tables - before the COVID-19 pandemic hit - duringthe course of his career.

NBC Sports Chicago recently caught up with "Kid Poker", who was promoting the streaming service PokerGO, and asked who he thought the best poker player in the world was.

"So for me, it's always going to be Phil Ivey until otherwise stated," Negreanu said over the phone. "When you say 'poker', I think of all poker games. I think of Stud, Omaha, Triple Draw, Short Deck, everything... and Phil Ivey plays them all. There are certainly going to be some players who play just No Limit Hold'em, the most famous game, better than Phil Ivey right now because people have worked really hard on it. But as far as I'm concerned, Phil Ivey is the goat."

Ivey has 10 WSOP bracelets and 59 cashes tohis poker portfolio, which earned him $6,261,200.

PokerGO is showing classic moments from the World Series of Poker every night at 7 p.m. ET.

Why Daniel Negreanu thinks Phil Ivey is the best poker player in the world originally appeared on NBC Sports Chicago

See the original post here:

Why Daniel Negreanu Thinks Phil Ivey Is the Best Poker Player in the World - NBC Chicago

Around the Wiregrass – Dothan Eagle

A telephone prayer lineis hosted Monday-Friday at 12:15 p.m. by Dothan Tabernacle Church of God in Christ in Dothan and Living Waters Church of God in Christ in Hartford. The public is invited to join the prayer line. Call 712-451-0464 and punch in the code 568383#. Participants should mute phones after successfully connecting.

The Disabled American Veterans Auxiliary Dothan Unit #87 will meet every third Thursday. Due to COVID-19, the location has been changed to Harvest Church at 2727 Fortner St. in Dothan. The group will follow guidelines from the Centers for Disease Control and Prevention, adhering to a 6-foot distance between participants and wearing masks. Call or text 334-596-9610 for more information.

Girl Scouts of Southern Alabama (GSSA) has partnered with the Alabama State Parks and Alabama Historical Commission for Every Girl In a Park, going on now through Oct. 31. All 21 Alabama State Parks and 14 Alabama Historic Sites are offering free admission for Girl Scouts and one accompanying adult, as long as they are wearing the Every Girl In a Park T-shirt. Alabama State Parks is also offering a 10% discount for campground rental or room rate at one of the lodges (discount does not apply to Gulf State Park). Discounts will be available now until Oct. 31 excluding Labor Day. For more information, visit http://www.girlscoutssa.org/everygirlinapark.

The Alfred Saliba Family Service Centers HIPPY Program, a free Kindergarten Readiness Program, is available in Barbour, Coffee, Dale, Geneva, Henry and Houston counties. HIPPY is Home Instruction for Parents of Preschool Youngsters. A 30-week, age-appropriate curriculum designed for 2-, 3-, 4- and 5-year-olds. Parents and children work just 10-15 minutes per day to close the academic gap by improving literacy, language, math, science, and physical and motor skills. Parents may enroll by phone, in-person or via Facebook. The program is funded by the Alabama Department of Early Childhood Education, Childrens Trust Fund of Alabama, and Wiregrass Foundation.

See more here:

Around the Wiregrass - Dothan Eagle

OPINION EXCHANGE | The last days of the tech emperors? – Minneapolis Star Tribune

On Wednesday, U.S. Rep. David Cicilline, D-R.I., and chairman of the House Judiciary Committees antitrust subcommittee, opened a half-virtual hearing on Online Platforms and Market Power with a combative opening statement: Our founders would not bow before a king. Nor should we bow before the emperors of the online economy.

That set the tone for the hours of sharp questioning of four of the wealthiest people on the planet: Jeff Bezos of Amazon, Tim Cook of Apple, Sundar Pichai of Google and Mark Zuckerberg of Facebook, whose companies have a combined market value roughly equivalent to the GDP of Japan.

Given the history of Silicon Valleys relationship with Washington, the intensity and precision of some subcommittee members questions were remarkable. It is a sign that significant tech regulation may be closer than we think.

Despite its techno-libertarian image, the tech industry has had close political ties for decades and remarkable success in getting what it wants.

In the late 1970s, venture capitalists and semiconductor chief executives got Capitol Hill and the Carter White House to agree to tax cuts and looser financial regulations. In the 1980s, a group of young legislators became such boosters of the industry that they were known as Atari Democrats. Ronald Reagan extolled Silicon Valley entrepreneurship and helped tech companies fend off Japanese competition.

The bipartisan love affair intensified in the 1990s as Bill Clinton and Al Gore invited tech executives to shape early internet-era policymaking. Newt Gingrich, then the Republican speaker of the House, talked up cyberspace and formed close alliances with libertarian-minded tech thinkers. His partys leaders convened high-tech summits on Capitol Hill.

The lightly regulated online economy we have today is a product of that decade, when Silicon Valley leaders persuaded starry-eyed lawmakers that young, scrappy internet companies could regulate themselves.

Washingtons embrace of tech continued even as questions emerged about the industrys wealth and power. A 2013 Senate hearing to interrogate Cook about Apples tax avoidance quickly was sidetracked by lawmakers gushing to the chief executive about his companys innovative products. Pichai faced tough questions at a 2018 House Judiciary hearing, but also was showered with praise.

Google is still the story of the American dream, declared Rep. Robert W. Goodlatte of Virginia, the committees chairman at the time.

Those days seemed a dim memory Wednesday. Instead, the mood recalled the traffic safety debates of the mid-1960s that helped catalyze significantly more regulation for the auto industry. After a steady drumbeat of studies and some short-lived congressional inquiries, traffic safety exploded into the public consciousness starting with Senate hearings in the summer of 1965, where top auto executives faced sharp questions about their lax approach to safety.

The evening network news programs showed Robert F. Kennedy, a newly elected senator from New York, grilling the leaders of General Motors about the tiny amount the company spent on safety research. Later that year a young lawyer advising the Senate committee, Ralph Nader, published a blockbuster expos of the industry, Unsafe at Any Speed.

This combination of political and media scrutiny led to passage of the National Traffic and Motor Vehicle Safety Act of 1966, which mandated seatbelts and additional car safety features, as well as road improvements like guardrails and traffic barriers.

Wednesday felt like Big Techs Ralph Nader moment: the pointed questioning by committee members, notably its Democratic women like Reps. Val Demings of Florida, Pramila Jayapal of Washington, Lucy McBath of Georgia and Mary Gay Scanlon of Pennsylvania; the crescendo of investigative journalism that, in part, led to this weeks hearing by shining a critical light on Big Techs practices. And now, this House subcommittee is merely one of several legislative or regulatory bodies considering limits on Big Techs power.

There are of course many reasons tech regulation may not come to pass. The issues at stake are wickedly complex, and quite different for each of these companies, something chief executives sought to underscore in the hearing.

It appears to me, Bezos observed, that social media is a nuance-destruction machine, and I dont think thats helpful for a democracy. (Zuckerbergs reaction to that statement sadly was not visible to the audience.)

Large tech companies also have prepared for the regulatory onslaught by starting some of the most well-funded lobbying operations in Washington. They learned a lesson from Microsoft, whose presence in the capital before its antitrust case in 1998 consisted of one employee who worked out of the back of his car because he lacked proper office space.

Although the trial didnt end with Microsoft being ordered to break itself apart, it taught the company that government regulators needed to be taken seriously. And as a result Microsoft tamped down its most aggressive market practices, and escaped much of the yearslong policy scrutiny now facing its peers.

Then there is the sticky problem of public opinion. During other seminal moments carmakers in the 1960s, tobacco in the 1990s the problems posed by unregulated bigness were clear-cut. Cigarettes killed people. Cars were unsafe.

Techs consumer dangers are harder to see and acutely feel on an average day: misinformation, an incomplete search result, a unfairly promoted link, privacy erosion, a skewed algorithm. We may wish we used our smartphones less, or worry about what overuse of social media is doing to our communities and brains.

But we still routinely check our Facebook pages, buy apps via Apple, and click buy on Amazon Prime. Even if, as some representatives noted, we do so because we have little alternative.

What happens next will depend on many things, including the November election. But this week marks the end of Washingtons great love affair with tech, one that helped make these companies bigness possible in the first place.

Margaret OMara is a contributing opinion writer for the New York Times and a history professor at the University of Washington in Seattle. She is the author of three books, most recently The Code: Silicon Valley and the Remaking of America, and has published widely on the history of the high-tech economy.

More here:

OPINION EXCHANGE | The last days of the tech emperors? - Minneapolis Star Tribune

Latin America & the Caribbean: COVID-19 External and Internal Access Restrictions (As of 27 July 2020) – World – ReliefWeb

Overview: Mexico & Central America

ACAPS included Costa Rica and Mexico in their July 2020 Humanitarian Access Overview as countries with deteriorating humanitarian access since their previous publication in October 2019. The overview rates Costa Ricas restriction of access to services and assistance as a 2 on a scale of 5, earning an overall access limitation severity rating of 1 out of 5. Mexicos overall rating was 2 due to ratings on restriction of access to services and assistance, internal movement restriction and interference with humanitarian activities, as well as ongoing insecurity and hostilities;ACAPS notes that only access restriction and ongoing hostilities are due to the pandemic.

Prolonged confinement measures in some countries are causing security concerns; Honduras has recorded 434 protests in 72 municipalities since 16 March, with nearly 70 per cent of the protests primarily spurred on by either access to food (35.3 per cent), demands to return to work (17.1 per cent) or state assistance payments (17.1 per cent).

With most borders still closed, populations rendered even more vulnerable by the pandemics impact are being left with increasingly fewer options amid declining economies, limited access to basic services and persistent violence. Costa Rica, who routinely fields anywhere from 3,000 to 4,000 asylum requests each month, mostly from Nicaraguan asylum seekers, reports fewer than 25 monthly requests in recent months

Read more from the original source:

Latin America & the Caribbean: COVID-19 External and Internal Access Restrictions (As of 27 July 2020) - World - ReliefWeb

Spinraza-Zolgensma Combination Well-tolerated in Children with SMA… – SMA News Today

Combining Spinraza(nusinersen) with the gene therapyZolgensma(onasemnogene abeparvovec-xioi) is generally well-tolerated and sustains motor improvements in children withspinal muscular atrophy(SMA) type1, according to a case series study.

The data, which included children treated with Zolgensma at older ages than those reported in clinical trials, suggested that older patients may be at a higher risk of developing gene therapiesknown side effects, such as liver dysfunction and low platelet counts.

However, further studies are needed to better characterize combination therapies safety and determine whether it is more beneficial than single therapy, especially considering their high cost, researchers noted.

The case series study, Combination molecular therapies for type 1 spinal muscular atrophy, was published in the journal Muscle & Nerve.

Currently available SMA therapies Biogens Spinraza andNovartis Zolgensma both work to restore the levels ofSMN, the protein lacking in SMA patients due tomutations in theSMN1gene.

Spinraza, the firstapproved disease-modifying therapy for all SMA patients, targetsSMN2, a backup gene that can compensate partially for the loss ofSMN1-derived SMN. The therapy is given directly into the spinal canal every four months.

In contrast, Zolgensma is administered directly into the bloodstream and delivers a functional copy ofSMN1to cells. It is available to children up to age 2 in theU.S.andJapan,and to almost all SMA types in those weighing up to 21 kilograms (about 46 pounds) inEurope.

The gene therapy can be given only once, due to the bodys natural immune reaction and production of antibodies against the modified virus it uses to deliver the gene to cells.

Nevertheless, immune reactions can still occur after the single dose, which can raise the levels of liver enzymes an indicator of liver damage and drop those of platelets.For that reason, it is recommended that patients liver function and platelet counts are monitored before, and at regular periods after, treatment.

While treatment combination aiming at increasing or sustaining motor function improvements is likely to occur in these patients, there is limited data on its safety and effectiveness.

Researchers now have reported the effects of combination therapy in five children with type 1 SMA followed at the Arkansas Childrens Hospital of the University of Arkansas for Medical Sciences and the Ann and Robert H. Lurie Childrens Hospital of Chicago.

Patients, who were 17 to 29 months of age at last assessment, received first treatment between 1.5 and 7 months and second therapy between 9 and 23 months.

Four children were treated first with Spinraza and then with Zolgensma, and three of them continued Spinraza treatment after that. One child received Zolgensma first, followed by Spinraza, and was the only one to receive the gene therapy within the age range (6.5 months) studied in clinical trials.

After the combination therapy, all patients continued to show motor function improvements, as assessed by theChildrens Hospital of Philadelphia Infant Test of Neuromuscular Disorders and the Hammersmith Infant Neurological Examination Part 2.

Increased levels of liver enzymes, indicating liver dysfunction, were detected in the four children who received Zolgensma after Spinraza and were successfully normalized withprednisolone treatment (recommended when given gene therapy).

Prednisolone therapy was prolonged beyond the previously reported duration range with Zolgensma (one to four months) in two patients who were hospitalized due to liver problems.

The researchers suspected that this rise in liver enzymes was related mainly to Zolgensma and noted that the fast reintroduction of Spinraza after Zolgensma may result in cumulative liver toxicity.

Interestingly, the two children receiving the gene therapy the latest (23 months, nearly 2 years) also showed asymptomatic low levels of platelets, which could possibly be explained by a more experienced immune system posing a robust immune response, the researchers wrote.

The child who received Zolgensma after Spinraza experienced no side effects.

These findings suggest that combining Spinraza with Zolgensma is generally well-tolerated in type 1 patients, but prolonged prednisolone use and liver toxicity monitoring may be necessary, the team noted.

It is unclear whether combination therapy augments SMN expression levels above either monotherapy approach, and, if so, whether the augmented level is more beneficial that that achieved with either monotherapy, the researchers wrote.

Further studies involving more patients are needed to better understand the effects of combination therapy in liver function and to determine whether there are circumstances in which combination therapy would be more efficacious than either monotherapy, the them concluded.

Recently, Biogen announced plans to launch a Phase 4 clinical trial, called RESPOND, evaluating the benefits ofSpinrazain approximately 60 infants and children withSMA who were treated previously with Zolgensma.

Marta Figueiredo holds a BSc in Biology and a MSc in Evolutionary and Developmental Biology from the University of Lisbon, Portugal. She is currently finishing her PhD in Biomedical Sciences at the University of Lisbon, where she focused her research on the role of several signalling pathways in thymus and parathyroid glands embryonic development.

Total Posts: 85

Ana holds a PhD in Immunology from the University of Lisbon and worked as a postdoctoral researcher at Instituto de Medicina Molecular (iMM) in Lisbon, Portugal. She graduated with a BSc in Genetics from the University of Newcastle and received a Masters in Biomolecular Archaeology from the University of Manchester, England. After leaving the lab to pursue a career in Science Communication, she served as the Director of Science Communication at iMM.

Original post:

Spinraza-Zolgensma Combination Well-tolerated in Children with SMA... - SMA News Today

Expression Therapeutics Announces Bill Swaney as VP of Manufacturing and the Construction of Cell and Gene Therapy Manufacturing – Yahoo Finance

ATLANTA, July 30, 2020 /PRNewswire/ --Expression Therapeutics has announced the appointment of Bill Swaney as the Vice President of Manufacturing. He comes to Expression Therapeutics from the Cincinnati Children's Hospital Medical Center where he was the Director of the Vector Production Facility & Viral Vector Core. Mr. Swaney is an internationally recognized expert in GMP cell and gene therapy manufacturing and has conducted over 70 GMP production runs for academic and commercial clients.

"We are pleased to welcome Bill, a pioneer in cell and gene therapy manufacturing, to Expression Therapeutics. Under his leadership, we now have a complete manufacturing team, making us one of the few biotechnology companies with its own therapeutic pipeline and in-house manufacturing, with the capability to provide CDMO services to commercial clients," said Mohan Rao, Ph.D., CEO of Expression Therapeutics.

Expression Therapeutics has also announced today the construction of a 43,000-sq ft manufacturing facility in Cincinnati, Ohio. The facility will manufacture lentiviral (LV), retroviral (RV), and adeno associated viral (AAV) GMP vectors,with a mix of 30-180 liter runs in cell stacks and up to 1,000 liter runs in bioreactors, and will have the capability to manufacture up to 100 GMP vector products per year. Additionally, it provides the necessary infrastructure to fulfill Expression Therapeutics' ex vivo cell processing and recombinant protein production needs. Expression Therapeutics is using prefabricated PODs from G-CON Manufacturing, Inc. for its ISO Class 7 cleanroom suites.

"We decided to utilize advanced pre-built modular cleanrooms from G-CON to accelerate our buildout and commence vector manufacturing this year. With vector GMP manufacturing backlogs today typically exceeding 18 months, we wanted to bring on additional capacity as soon as possible to serve clients," said Bill Swaney, Vice President of Manufacturing for Expression Therapeutics.

Expression Therapeutics is a biotechnology company based in Atlanta and Cincinnati. The current therapeutic pipeline includes advanced gene therapies for hemophilia, neuroblastoma, T-cell leukemia/lymphoma, acute myeloid leukemia (AML), and primary immunodeficiencies such as hemophagocytic lymphohistiocytosis (HLH).

For manufacturing inquiries, please contact Bill Swaney at wswaney@expressiontherapeutics.com.

For all other inquiries, please contact: Ashley Walsh Director of Corporate Development Expression Therapeutics 1860 Montreal Road Tucker, Georgia 30084 awalsh@expressiontherapeutics.com +1 312.637.2975

(PRNewsfoto/Expression Therapeutics)

View original content to download multimedia:http://www.prnewswire.com/news-releases/expression-therapeutics-announces-bill-swaney-as-vp-of-manufacturing-and-the-construction-of-cell-and-gene-therapy-manufacturing-301103194.html

SOURCE Expression Therapeutics

Original post:

Expression Therapeutics Announces Bill Swaney as VP of Manufacturing and the Construction of Cell and Gene Therapy Manufacturing - Yahoo Finance

Vineti and EVERSANA form strategic alliance to advance patient-centered services and supply chain automation for regenerative medicine – PRNewswire

The Vineti/EVERSANA partnership looks at the cell and gene therapy lifecycle holistically and tracks both the product and patient journeys concurrently. EVERSANA's pre- and post-commercial launch services effectively plan market access, clinical trial recruitment, global pricing, patient and HCP engagement, patient and market access and adherence support, therapy storage and distribution needs, and outcomes measurement, with each step measured and optimized by a fully integrated data and analytics platform.

Vineti's Personalized Therapy Management platform automates the Chain of Identity, Chain of Custody and Chain of Condition while enabling the sophisticated scheduling of manufacturing and shipping to hospitals and labs worldwide with industry-leading user experience.

Under the alliance, clients will be able to view patient orders that originated from Vineti and are supported by EVERSANA's integrated commercial services, giving a full view of the patient and product journeys and saving time going back and forth between systems and multiple vendors.

"We're very excited to partner with EVERSANA to help overcome the inherent complexity of cell and gene therapies and provide efficient, integrated solutions for manufacturers and patients," said Vineti CEO and Co-founder Amy DuRoss. "Vineti is focused on industrializing advanced therapies so that all patients in need can benefit. This type of integrated solution with EVERSANA is essential to that goal."

"We're amazed when we look at the pipeline for cell and gene therapies and the hope that's been created for millions of patients worldwide. But as an industry, we have to make that hope a reality by tackling the access, affordability and logistics challenges in this sector," said Jim Lang, CEO, EVERSANA. "That's why we are partnering with best-in-class technology providers like Vineti who share our vision for an accelerated regenerative medicine pipeline that gets products to patients safely, effectively and in a value- and data-driven model. Innovators carry less risk and more financial predictability, while their patients have the promise of healthier lives."

The alliance ensures that EVERSANA clients will be able to view patient orders that originated from Vineti, giving them a full view of the patient journey and saving time going back and forth between systems. Vineti clients will be able to access EVERSANA's solutions through the Vineti Alliance Network.

Media

Stacy Henry Vineti[emailprotected]

Sarah Zwicky EVERSANA[emailprotected]

About Vineti

Vineti is the first commercial, configurable cloud-based platform to expand patient access to life-saving cell and gene therapies. Vineti was co-founded by GE and the Mayo Clinic to solve the key challenges that patients, medical providers, biopharmaceutical companies and regulators face in the delivery and commercialization of individualized therapies. Now a fully independent company, Vineti offers a digital platform of record to integrate logistics, manufacturing and clinical data for personalized therapies. The Vineti platform supports the full continuum of patient-specific therapies, including cancer vaccines and autologous and allogeneic therapies. The company is expanding rapidly, and Vineti's Personalized Therapy Management (PTM) platform was in use in hundreds of leading medical centers worldwide in 2019, on behalf of multiple biopharmaceutical partners. In 2019, the World Economic Forum selected Vineti as a global Technology Pioneer.

About EVERSANA

EVERSANA is the leading provider of global services to the life science industry. The company's integrated solutions are rooted in the patient experience and span all stages of the product lifecycle to deliver long-term, sustainable value for patients, prescribers, channel partners and payers. The company serves more than 500 organizations, including innovative start-ups and established pharmaceutical companies, to advance life science solutions for a healthier world. To learn more about EVERSANA, visit eversana.com or connect through LinkedIn and Twitter.

SOURCE Eversana

Home

Continue reading here:

Vineti and EVERSANA form strategic alliance to advance patient-centered services and supply chain automation for regenerative medicine - PRNewswire

Orchard Therapeutics to Webcast Conference Call of Second Quarter 2020 Financial Results – GlobeNewswire

BOSTON and LONDON, July 30, 2020 (GLOBE NEWSWIRE) -- Orchard Therapeutics (Nasdaq: ORTX), a global gene therapy leader, today announced that the company will host a conference call and live webcast on Thursday, August 6, 2020, at 8:00 a.m. ET to review business updates and its second quarter 2020 financial results.

A live webcast will be available under "News & Events" in the Investors & Media section of the company's website at http://www.orchard-tx.com. The conference call can be accessed by dialing (866) 987-6504 (U.S. domestic) or +1 (602) 563-8620 (international) and referring to conference ID 7392139. A replay of the webcast will be archived on the Orchard website following the presentation.

About Orchard

Orchard Therapeutics is a global gene therapy leader dedicated to transforming the lives of people affected by rare diseases through the development of innovative, potentially curative gene therapies. Our ex vivo autologous gene therapy approach harnesses the power of genetically modified blood stem cells and seeks to correct the underlying cause of disease in a single administration. In 2018, Orchard acquired GSKs rare disease gene therapy portfolio, which originated from a pioneering collaboration between GSK and the San Raffaele Telethon Institute for Gene Therapy in Milan, Italy. Orchard now has one of the deepest and most advanced gene therapy product candidate pipelines in the industry spanning multiple therapeutic areas where the disease burden on children, families and caregivers is immense and current treatment options are limited or do not exist.

Orchard has its global headquarters in London and U.S. headquarters in Boston. For more information, please visit http://www.orchard-tx.com, and follow us on Twitter and LinkedIn.

Availability of Other Information About Orchard

Investors and others should note that Orchard communicates with its investors and the public using the company website (www.orchard-tx.com), the investor relations website (ir.orchard-tx.com), and on social media (TwitterandLinkedIn), including but not limited to investor presentations and investor fact sheets,U.S. Securities and Exchange Commissionfilings, press releases, public conference calls and webcasts. The information that Orchard posts on these channels and websites could be deemed to be material information. As a result, Orchard encourages investors, the media, and others interested in Orchard to review the information that is posted on these channels, including the investor relations website, on a regular basis. This list of channels may be updated from time to time on Orchards investor relations website and may include additional social media channels. The contents of Orchards website or these channels, or any other website that may be accessed from its website or these channels, shall not be deemed incorporated by reference in any filing under the Securities Act of 1933.

Contacts

Investors

Renee LeckDirector, Investor Relations+1 862-242-0764Renee.Leck@orchard-tx.com

View original post here:

Orchard Therapeutics to Webcast Conference Call of Second Quarter 2020 Financial Results - GlobeNewswire

Global Gene Therapy Market Market Analysis by SWOT, Investment, Future Growth and Major Key Players 2020 to 2025 – Research Newspaper

The Gene Therapy Market market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

It incorporates Gene Therapy Market market evolution study, involving the current scenario, growth rate (CAGR), and SWOT analysis. Important the study on Gene Therapy Market market takes a closer look at the top market performers and monitors the strategies that have enabled them to occupy a strong foothold in the market. Apart from this, the research brings to light real-time data about opportunities that will completely transform the trajectory of the business environment in the coming years to 2025. Some of the key players in the global Gene Therapy Market market is Sangamo, Spark Therapeutics, Dimension Therapeutics, Avalanche Bio, Celladon, Vical, Advantagene.

Download Sample Copy of the Report to understand the structure of the complete report (Including Full TOC, Table & Figures) @ https://brandessenceresearch.com/requestSample/PostId/417

Gene Therapy Market Market: Competitive Landscape:

The competitive landscape further includes details about different players and their position on a global and a local level is also explained in detail in this compiled study. These insights were prepared through mapping business strategies and products that offer high revenue generation capacities. An overview of the Gene Therapy Market market Comprehensive analysis of the market Analyses of recent developments in the market Events in the market scenario of the past few years Emerging market segments and regional Gene Therapy Market markets Segmentations up to the second and/or third level Historical, current, and estimated market size in terms of value and volume Competitive analysis, with company overview, products, revenue, and strategies. An impartial assessment of the market Strategic recommendations to help companies increase their Gene Therapy Market market presence.

The Key Manufacturers covered in this Report:- Sangamo, Spark Therapeutics, Dimension Therapeutics, Avalanche Bio, Celladon, Vical, Advantagene.

By Therapy Type:-SomaticGermlineBy Vector Type:-

non-viral Vectorsviral vectorsBy Application:-

Cancer DiseasesMonogenic DiseasesInfectious DiseasesCardiovascular Diseases Others

The key regions covered in the Gene Therapy Market market report are:

North America (U.S., Canada, Mexico)

South America (Cuba, Brazil, Argentina, and many others.)

Europe (Germany, U.K., France, Italy, Russia, Spain, etc.)

Asia (China, India, Russia, and many other Asian nations.)

Pacific region (Indonesia, Japan, and many other Pacific nations.)

Middle East & Africa (Saudi Arabia, South Africa, and many others.)

Request Customization of the Report: https://brandessenceresearch.com/requestSample/PostId/417

Table of Contents

Report Overview: It includes major players of the global Gene Therapy Market Market covered in the research study, research scope, and Market segments by type, market segments by application, years considered for the research study, and objectives of the report.

Global Growth Trends: This section focuses on industry trends where market drivers and top market trends are shed light upon. It also provides growth rates of key producers operating in the global Gene Therapy Market Market. Furthermore, it offers production and capacity analysis where marketing pricing trends, capacity, production, and production value of the global Gene Therapy Market Market are discussed.

Market Share by Manufacturers: Here, the report provides details about revenue by manufacturers, production and capacity by manufacturers, price by manufacturers, expansion plans, mergers and acquisitions, and products, market entry dates, distribution, and market areas of key manufacturers.

Market Size by Type: This section concentrates on product type segments where production value market share, price, and production market share by product type are discussed.

Market Size by Application: Besides an overview of the global Gene Therapy Market Market by application, it gives a study on the consumption in the global Gene Therapy Market Market by application.

Production by Region: Here, the production value growth rate, production growth rate, import and export, and key players of each regional market are provided.

Consumption by Region:This section provides information on the consumption in each regional market studied in the report. The consumption is discussed on the basis of country, application, and product type.

Company Profiles:Almost all leading players of the global Gene Therapy Market Market are profiled in this section. The analysts have provided information about their recent developments in the global Gene Therapy Market Market, products, revenue, production, business, and company.

Market Forecast by Production:The production and production value forecasts included in this section are for the global Gene Therapy Market Market as well as for key regional markets.

Market Forecast by Consumption:The consumption and consumption value forecasts included in this section are for the global Gene Therapy Market Market as well as for key regional markets.

Value Chain and Sales Analysis:It deeply analyzes customers, distributors, sales channels, and value chain of the global Gene Therapy Market Market.

Key Findings: This section gives a quick look at important findings of the research study.

Get access to full summary @ https://brandessenceresearch.com/healthcare/gene-therapy-market-global

About Us:

We publish market research reports & business insights produced by highly qualified and experienced industry analysts. Our research reports are available in a wide range of industry verticals including aviation, food & beverage, healthcare, ICT, Construction, Chemicals and lot more. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations and Ph.D. Students.

Top Trending Reports:

https://www.marketwatch.com/press-release/global-ipaas-market-analysis-2020-2025-covering-recent-trend-and-future-growth-feasibility-regional-outlook-and-future-forecast-2020-05-27

https://www.marketwatch.com/press-release/magnesium-oxide-market-global-industry-analysis-and-opportunity-assessment-2020-2025-2020-05-27

https://www.marketwatch.com/press-release/cloud-telephony-service-market-2020-by-advanced-technologies-growth-opportunities-key-players-revenue-emerging-trends-and-business-strategy-till-2025-2020-05-27

https://www.marketwatch.com/press-release/global-phosphate-fertilizers-market-2020-share-trends-segmentation-and-forecast-to-2025-2020-06-15

https://www.marketwatch.com/press-release/carbonated-beverages-market-2020-industry-research-share-trend-global-industry-size-price-future-analysis-regional-outlook-to-2025-2020-06-15

Read more from the original source:

Global Gene Therapy Market Market Analysis by SWOT, Investment, Future Growth and Major Key Players 2020 to 2025 - Research Newspaper

REGENXBIO To Host Conference Call on August 6 to Discuss Second Quarter 2020 Financial Results and Recent Operational Highlights – PRNewswire

ROCKVILLE, Md., July 30, 2020 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX), a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy based on its proprietary NAVTechnology Platform, today announced that it will host a conference call on Thursday, August 6, 2020, at 4:30 p.m. ET to discuss its financial results for the quarter ended June 30, 2020, and recent operational highlights.

To access the live call by phone, dial (800) 708-4539 (domestic) or (800) 619-6396 (international) and enter the passcode 49857700. To access a live or recorded webcast of the call, please visit the Investors section of the REGENXBIO website at http://www.regenxbio.com. The recorded webcast will be available for approximately 30 days following the call.

AboutREGENXBIO Inc.

REGENXBIO is a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy. REGENXBIO's NAV Technology Platform, a proprietary adeno-associated virus (AAV) gene delivery platform, consists of exclusive rights to more than 100 novel AAV vectors, including AAV7, AAV8, AAV9 and AAVrh10. REGENXBIO and its third-party NAV Technology Platform Licensees are applying the NAV Technology Platform in the development of a broad pipeline of candidates in multiple therapeutic areas.

Contacts:

Tricia TruehartInvestor Relations and Corporate Communications347-926-7709[emailprotected]

Investors:Eleanor Barisser, 212-600-1902[emailprotected]

Media:David Rosen, 212-600-1902[emailprotected]

SOURCE REGENXBIO Inc.

http://www.regenxbio.com

Read the rest here:

REGENXBIO To Host Conference Call on August 6 to Discuss Second Quarter 2020 Financial Results and Recent Operational Highlights - PRNewswire

As The Bitcoin Price Soars, Bitcoins Real Crypto Market Dominance Is Revealed – Forbes

Bitcoin has soared this week, rocketing above $11,000 for the first time since August last year and adding around 20% in just a few days.

Some smaller cryptocurrencies have made massive gains in recent months as bitcoin treaded water, eating into bitcoin's dominancea measure of bitcoin's value compared to the wider cryptocurrency market.

However, some have suggested bitcoin's dominance should only be measured against other cryptocurrencies that are "attempting to be money," putting bitcoin's "real" dominance at almost 80%, up from just over 60% by other measures.

The bitcoin price has rallied this week, climbing above the psychological $10,000 per bitcoin level. ... [+]

According to the new measure of bitcoin dominance, bitcoin currently makes up 79% of the cryptocurrency marketup from the 62% bitcoin market share calculated by the oft-cited crypto data website CoinMarketCap, which takes into account hundreds of cryptocurrencies that are all created and issued in different ways.

The Real Bitcoin Dominance Index, created by Buy Bitcoin Worldwide founder Jordan Tuwiner, calculates bitcoin's market share among cryptocurrencies that are created, or "mined," in a similar way to bitcoin.

The new bitcoin dominance index also excludes all cryptocurrencies issued as a form of fundraising, known as initial coin offerings (ICOs), cryptocurrencies tied to traditional currencies, such as tether, and other centralized projects, making it "a better measure" of the cryptocurrency market, according to Tuwiner.

"The issue with ICOs is that they are centrally controlled. Let's say a bitcoin exchange releases stock legally via a token. Other dominance indexes would likely include that in their index. If so, then why not include the whole stock market? ICOs or stocks that are tokens are not trying to be money, and therefore should not be measured in a dominance index with bitcoin," Tuwiner said via email.

"Bitcoin is competing as money and not as stock or a token. Stablecoins, while they are easier to transfer than normal fiat in a bank, are still just tokens backed by fiat. Coins that do not use proof of work can be pre-mined, or are not actually scarce since no real work is required to produce them."

The Real Bitcoin Dominance Index is made up of 12 bitcoin rivals, including litecoin, sometimes referred to as "the silver to bitcoin's gold," bitcoin offshoots bitcoin cash and bitcoin SV, privacy-focused cryptocurrency monero, and "joke" meme-based token dogecoin.

Bitcoin dominance over the wider cryptocurrency market has declined so far this year as so-called ... [+] altcoins have rallied.

"There's likely hundreds if not thousands of coins on most dominance indexes that are artificially inflated," Tuwiner said, pointing to "centralized ICOs" that "can pre-mine coins and create artificially high market caps."

"None of the coins used in the index are pre-mined, besides ethereum," Tuwiner said.

"There was a debate whether or not to include ethereum, but we ultimately left it since it's the second biggest coin and is used by people as money. There is an option to turn it on or off because the crypto community is split on whether ethereum can function as money."

If ethereum, which currently has a total value of $37 billion compared to bitcoin's $204 billion, is excluded from the index bitcoin's dominance increases to 92%.

Tuwiner feels that the dominance measures that include all manner of cryptocurrencies can create confusion about how other cryptocurrencies relate to bitcoin, saying: "I think it would be good for other sites to offer both metrics. One without ICOs or stablecoinsand one with the entire 'crypto' market capitalization."

Others have expressed concerns that any measure of bitcoin dominance that uses cryptocurrency valuations could have issues.

"In general there are a lot of problems with using market capitalizations to determine dominance," Jameson Lopp, the cofounder and chief technology officer of bitcoin storage service Casa, said via email, though he added, "the arguments made by the Real Bitcoin Dominance Index make sense to me."

"Dominance generally seems like a vanity metric and different sites use different algorithms to calculate it. Trying to argue about which assets should qualify as money tends to devolve into subjectivity.

"I think that if you're going to measure 'dominance' then it should be in the context of all forms of money that are competing with each other, not just crypto projects."

Read more from the original source:

As The Bitcoin Price Soars, Bitcoins Real Crypto Market Dominance Is Revealed - Forbes

Coinbase Planning Addition of Balancer, Helium, and 17 More Cryptos – Finance Magnates

Coinbase, the leading crypto exchange in the United States, is considering the addition of 19 more digital currencies that include tokens from the decentralized finance (DeFi) ecosystem to wrapped cryptos.

As announced on Friday in an official blog post, all the cryptocurrencies on Coinbases list are Ampleforth, Band Protocol, Balancer, Blockstack, Curve, Fetch.ai, Flexacoin, Helium, Hedera Hashgraph, Kava, Melon, Ocean Protocol, Paxos Gold, Reserve Rights, tBTC, The Graph, THETA, UMA, and WBTC.

The Most Diverse Audience to Date at FMLS 2020 Where Finance Meets Innovation

Coinbase detailed that the additions of these coins will require significant technical and compliance review in the part of the exchange, and in some cases even a green light from the local regulators.

We, therefore, cannot guarantee whether or when any above-listed asset will be listed on a Coinbase product in any jurisdiction, the San Francisco-based exchange stated.

What Trading Companies Really Need to Increase Their RevenuesGo to article >>

The popular crypto exchange and wallet platform also detailed that it will follow a jurisdiction-by-jurisdiction approach in listing the digital currencies, meaning its users some jurisdiction might get their access early compared to others.

As part of the exploratory process customers may see public-facing APIs and other signs that we are conducting engineering work to potentially support these assets, Coinbase added.

The move came when the cryptocurrency market is gaining steam and is slowly moving towards a bull run again major cryptos like Bitcoin and Ethereum have recently breached major resistance levels.

Following the news of possible Coinbase listing, most of the coins have surged significantly Ocean Protocol is among the leading gainers jumping over 17 percent in the last 24 hours, while Balancer also gained in double-digits, as seen onCornmarketcap.com.

This surge in prices with major listing is usual with crypto as, last May, Maker, the token of one of the major DeFi platform, surged 37 percent with a listing on Coinbase.

See the rest here:

Coinbase Planning Addition of Balancer, Helium, and 17 More Cryptos - Finance Magnates

The Astronauts SpaceX Crew Dragon Capsule Are Returning To Earth – NPR

NASA astronauts (from left) Bob Behnken, Doug Hurley and Chris Cassidy are the U.S. members of the Expedition 63 crew aboard the International Space Station. Behnken and Hurley are scheduled to return to Earth on Aug. 2. NASA hide caption

NASA astronauts (from left) Bob Behnken, Doug Hurley and Chris Cassidy are the U.S. members of the Expedition 63 crew aboard the International Space Station. Behnken and Hurley are scheduled to return to Earth on Aug. 2.

Updated 7:30 p.m. ET Saturday

The two astronauts that blasted off in the first private space vehicle to take people to the International Space Station are about to return to Earth by splashing down in the waters around Florida.

This will be the first planned splashdown for space travelers since 1975, although a Russian Soyuz capsule did have to do an emergency lake landing in 1976.

NASA astronaut Douglas Hurley says that he and his crewmate Robert Behnken are prepared for the possibility of seasickness.

"Just like on an airliner, there are bags if you need them. And we'll have those handy," Hurley said in a press conference held on Friday, while on board the station. "And if that needs to happen, it certainly wouldn't be the first time that that's happened in a space vehicle. It will be the first time in this particular vehicle, if we do."

The astronauts will come home in the same SpaceX Dragon capsule that took them up on May 30. Their flight marked the first time people had been launched to orbit from U.S. soil since NASA retired its space shuttles in 2011.

The success of their trip in the SpaceX vehicle has been a major milestone for commercial space travel, and a vindication of NASA's long-term plan to rely on space taxis for routine flights to and from the orbiting outpost while the government agency focuses on developing vehicles for a return to the moon.

The Dragon "Endeavour" capsule undocked from the International Space Station on Saturday at 7:34 p.m. ET. They will spend the night in orbit before heading home, with the splashdown scheduled for 2:48 p.m. ET on Sunday. NASA administrator Jim Bridenstine confirmed Saturday afternoon that the crew will target a splashdown site off the coast of Pensacola as the primary location. Conditions there are a "Go," according to the space agency.

"We have confidence that the teams on the ground are, of course, watching that much more closely than we are," Behnken said. "And we won't leave the space station without some good landing opportunities in front of us, good splashdown weather in front of us."

An alternative site off the coast of Panama City in the Gulf of Mexico is still being monitored should the crew need to switch locations. While Tropical Storm Isaias is headed for Florida, it is currently expected to hit the state's east coast.

Their mission is technically a demonstration flight it is the final test for SpaceX's crew system to be certified by NASA as 'operational' for future astronaut missions to and from the space station.

Already, NASA has assigned astronauts to future SpaceX Crew Dragon flights including Megan McArthur, who happens to be married to Behnken.

"She's super excited to be assigned to a SpaceX mission," says Behnken, who says the thing about his return to Earth that he's looking forward to the most is seeing his wife and son.

"My son is six years old," says Behnken, "and I can tell from the videos that I get, and talking to him on the phone, that he's changed a lot even in just the couple of months that we've been up here."

More:

The Astronauts SpaceX Crew Dragon Capsule Are Returning To Earth - NPR